Sign in Register

Indication

Burkitt's lymphoma

Burkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems. Read more about Burkitt's lymphoma

182 drugs 116 manufacturers

Advertisement

Drugs that treat it

Common Burkitt's lymphoma therapies.

Showing 109–117 of 182 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Laboratories Div

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
Major Pharamceuticals
Filter & compare in the drug finder →Opens the drug finder with Burkitt's lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon

Related conditions & guidelines

Coming soon

About Burkitt's lymphoma.

Burkitt's lymphoma is an aggressive, rapidly proliferating form of mature B-cell non-Hodgkin lymphoma that primarily involves the lymphatic and hematologic systems.

It is pathologically characterized by the translocation and deregulation of the *MYC* oncogene on chromosome 8, leading to extremely high rates of cellular proliferation and a classic "starry-sky" histologic appearance.

The malignancy presents in three epidemiological clinical variants—endemic, sporadic, and immunodeficiency-associated—frequently affecting children, young adults, and individuals with HIV or other immunocompromised states.

Patients commonly present with acute, rapidly enlarging extranodal tumor masses involving the jaw and facial bones, abdomen, gastrointestinal tract, central nervous system, or bone marrow.

Personalize your experience

Follow Burkitt's lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it